Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Bruzzi

Showing results (131-140 of 155) with videos related to

Pageof 16
Sort By:
Cytokine & Growth Factor Reviews|February 21, 2021
Anticancer innovative therapy congress: Highlights from the 10th anniversary editionFrancesca De Santis, Giovanni Fucà, Dirk Schadendorf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2002
Time to progression in metastatic breast cancer patients treated with epirubicin is not improved by the addition of either cisplatin or lonidamine: final results of a phase III study with a factorial designAlfredo Berruti, Raffaella Bitossi, Gabriella Gorzegno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for NeuroblastomaBruno De Bernardi, Brigitte Nicolas, Luca Boni, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 7, 2016
Comparison of coronary flow reserve estimated by dynamic radionuclide SPECT and multi-detector x-ray CTCecilia Marini, Sara Seitun, Camilla Zawaideh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Phase II study of asparagine-glycine-arginine-human tumor necrosis factor alpha, a selective vascular targeting agent, in previously treated patients with malignant pleural mesotheliomaVanesa Gregorc, Paolo A Zucali, Armando Santoro, et al.
European Journal of Cancer (Oxford, England : 1990)|December 13, 2016
Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studiesMatteo Lambertini, Marcello Ceppi, Francesco Cognetti, et al.
Lancet (London, England)|March 6, 2015
Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trialLucia Del Mastro, Sabino De Placido, Paolo Bruzzi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 17, 2016
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosisCecilia Marini, Angelina Cistaro, Cristina Campi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 25, 2017
Doxorubicin Effect on Myocardial Metabolism as a Prerequisite for Subsequent Development of Cardiac Toxicity: A Translational <sup>18</sup>F-FDG PET/CT ObservationMatteo Bauckneht, Giulia Ferrarazzo, Francesco Fiz, et al.
JAMA|July 27, 2007
Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathyBarry J Maron, Paolo Spirito, Win-Kuang Shen, et al.
Pageof 16

Showing results (131-140 of 155) with videos related to

Sort By:
Pageof 16
Cytokine & Growth Factor Reviews|February 21, 2021
Anticancer innovative therapy congress: Highlights from the 10th anniversary editionFrancesca De Santis, Giovanni Fucà, Dirk Schadendorf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2002
Time to progression in metastatic breast cancer patients treated with epirubicin is not improved by the addition of either cisplatin or lonidamine: final results of a phase III study with a factorial designAlfredo Berruti, Raffaella Bitossi, Gabriella Gorzegno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for NeuroblastomaBruno De Bernardi, Brigitte Nicolas, Luca Boni, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 7, 2016
Comparison of coronary flow reserve estimated by dynamic radionuclide SPECT and multi-detector x-ray CTCecilia Marini, Sara Seitun, Camilla Zawaideh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Phase II study of asparagine-glycine-arginine-human tumor necrosis factor alpha, a selective vascular targeting agent, in previously treated patients with malignant pleural mesotheliomaVanesa Gregorc, Paolo A Zucali, Armando Santoro, et al.
European Journal of Cancer (Oxford, England : 1990)|December 13, 2016
Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studiesMatteo Lambertini, Marcello Ceppi, Francesco Cognetti, et al.
Lancet (London, England)|March 6, 2015
Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trialLucia Del Mastro, Sabino De Placido, Paolo Bruzzi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 17, 2016
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosisCecilia Marini, Angelina Cistaro, Cristina Campi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 25, 2017
Doxorubicin Effect on Myocardial Metabolism as a Prerequisite for Subsequent Development of Cardiac Toxicity: A Translational <sup>18</sup>F-FDG PET/CT ObservationMatteo Bauckneht, Giulia Ferrarazzo, Francesco Fiz, et al.
JAMA|July 27, 2007
Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathyBarry J Maron, Paolo Spirito, Win-Kuang Shen, et al.
Pageof 16